ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 191 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,250,000 | $144,218,000 | 15.05% |
| Baker Brothers Advisors | 19,955,126 | $548,167,000 | 7.79% |
| HARVEY CAPITAL MANAGEMENT INC | 508,000 | $13,954,000 | 7.08% |
| RA Capital Management | 2,035,510 | $55,915,000 | 5.84% |
| Bodri Capital Management, LLC | 150,000 | $4,121,000 | 2.40% |
| Cupps Capital Management, LLC | 920,017 | $25,272,000 | 1.64% |
| Perceptive Advisors | 1,221,230 | $33,548,000 | 1.38% |
| Geduld E E | 80,000 | $2,198,000 | 1.34% |
| Alkeon Capital Management | 1,709,200 | $46,951,000 | 0.92% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,205,651 | $33,119,000 | 0.90% |